262 reports of this reaction
1.4% of all MISOPROSTOL reports
#19 most reported adverse reaction
MENORRHAGIA is the #19 most commonly reported adverse reaction for MISOPROSTOL, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 262 FDA adverse event reports linking MISOPROSTOL to MENORRHAGIA. This represents approximately 1.4% of all 18,857 adverse event reports for this drug.
Patients taking MISOPROSTOL who experience menorrhagia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MENORRHAGIA is a less commonly reported adverse event for MISOPROSTOL, but still significant enough to appear in the safety profile.
In addition to menorrhagia, the following adverse reactions have been reported for MISOPROSTOL:
The following drugs have also been linked to menorrhagia in FDA adverse event reports:
MENORRHAGIA has been reported as an adverse event in 262 FDA reports for MISOPROSTOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
MENORRHAGIA accounts for approximately 1.4% of all adverse event reports for MISOPROSTOL, making it a notable side effect.
If you experience menorrhagia while taking MISOPROSTOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.